Day One Biopharmaceuticals Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 178

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $2.5B

  • Investors
  • 1

Day One Biopharmaceuticals General Information

Description

Developer of targeted oncology therapies intended to treat patients with genetically defined cancers. The company's platform utilizes a search and development strategy to advance oral, brain-penetrant kinase inhibitors and antibody-drug conjugates, enabling healthcare providers to treat pediatric and adult patients living with low-grade gliomas and various solid tumors.

Contact Information

Formerly Known As
Hero Therapeutics Hoilding Company, Day One Biopharmaceuticals Holding Co
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 1800 Sierra Point Parkway
  • Suite 200
  • Brisbane, CA 94005
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Parent Company
Vertical(s)
Corporate Office
  • 1800 Sierra Point Parkway
  • Suite 200
  • Brisbane, CA 94005
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Day One Biopharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 23-Apr-2026 $2.5B Completed Generating Revenue
6. PIPE 01-Aug-2024 Completed Generating Revenue
5. 2PO 07-Jun-2023 Completed Generating Revenue
4. 2PO 15-Jun-2022 Completed Generating Revenue
3. IPO 27-May-2021 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Feb-2021 $130M $190M Completed Generating Revenue
1. Early Stage VC (Series A) 21-May-2020 $60M $60M Completed Generating Revenue
To view Day One Biopharmaceuticals’s complete valuation and funding history, request access »

Day One Biopharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of targeted oncology therapies intended to treat patients with genetically defined cancers. The company's plat
Drug Discovery
Brisbane, CA
178 As of 2025

San Diego, CA
 

Santa Monica, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Day One Biopharmaceuticals Competitors (6)

One of Day One Biopharmaceuticals’s 6 competitors is Lite Strategy, a Corporation company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lite Strategy Corporation San Diego, CA
Kite Pharma Formerly VC-backed Santa Monica, CA
CytomX Therapeutics Formerly VC-backed South San Francisco, CA
Aura Biosciences Formerly VC-backed Boston, MA
Xynomic Pharmaceuticals Formerly VC-backed Poway, CA
To view Day One Biopharmaceuticals’s complete competitors history, request access »

Day One Biopharmaceuticals Patents

Day One Biopharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024381999-A1 Methods of treating pediatric low-grade glioma Pending 15-Nov-2023
EP-4808559-A1 Methods of treating pediatric low-grade glioma Pending 15-Nov-2023
WO-2025106686-A1 Methods of treating pediatric low-grade glioma Inactive 15-Nov-2023
AU-2023272583-A1 Oral liquid suspension of pan-raf kinase inhibitor Pending 16-May-2022
EP-4525876-A1 Oral liquid suspension of pan-raf kinase inhibitor Pending 16-May-2022 A61K9/10
To view Day One Biopharmaceuticals’s complete patent history, request access »

Day One Biopharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Day One Biopharmaceuticals Former Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds
Atlas Venture Venture Capital Minority
BVF Partners Hedge Fund Minority
Boxer Capital Corporate Venture Capital Minority
Braidwell Hedge Fund Minority
Canaan Partners Venture Capital Minority
You’re viewing 5 of 17 investors. Get the full list »

Day One Biopharmaceuticals Acquisitions (1)

Day One Biopharmaceuticals’s most recent deal was a Merger/Acquisition with Mersana Therapeutics for . The deal was made on 06-Jan-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Mersana Therapeutics 06-Jan-2026 Merger/Acquisition Drug Discovery
To view Day One Biopharmaceuticals’s complete acquisitions history, request access »

Day One Biopharmaceuticals ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

35.09 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Biotechnology

Subindustry

of 431

Rank

Percentile

To view Day One Biopharmaceuticals’s complete esg history, request access »

Day One Biopharmaceuticals Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Mersana Therapeutics Cambridge, MA 2001

Day One Biopharmaceuticals FAQs

  • When was Day One Biopharmaceuticals founded?

    Day One Biopharmaceuticals was founded in 2018.

  • Where is Day One Biopharmaceuticals headquartered?

    Day One Biopharmaceuticals is headquartered in Brisbane, CA.

  • What is the size of Day One Biopharmaceuticals?

    Day One Biopharmaceuticals has 178 total employees.

  • What industry is Day One Biopharmaceuticals in?

    Day One Biopharmaceuticals’s primary industry is Drug Discovery.

  • Is Day One Biopharmaceuticals a private or public company?

    Day One Biopharmaceuticals is a Private company.

  • What is the current valuation of Day One Biopharmaceuticals?

    The current valuation of Day One Biopharmaceuticals is .

  • What is Day One Biopharmaceuticals’s current revenue?

    The current revenue for Day One Biopharmaceuticals is .

  • How much funding has Day One Biopharmaceuticals raised over time?

    Day One Biopharmaceuticals has raised $825M.

  • Who are Day One Biopharmaceuticals’s investors?

    Atlas Venture, BVF Partners, Boxer Capital, Braidwell, and Canaan Partners are 5 of 17 investors who have invested in Day One Biopharmaceuticals.

  • Who are Day One Biopharmaceuticals’s competitors?

    Lite Strategy, Kite Pharma, CytomX Therapeutics, Aura Biosciences, and Xynomic Pharmaceuticals are some of the 6 competitors of Day One Biopharmaceuticals.

  • When was Day One Biopharmaceuticals acquired?

    Day One Biopharmaceuticals was acquired on 23-Apr-2026.

  • Who acquired Day One Biopharmaceuticals?

    Day One Biopharmaceuticals was acquired by Servier.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process